These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12647268)
1. Atherogenic role of lysophosphatidylcholine in low-density lipoprotein modified by phospholipase A2 and in diabetic patients: protection by nitric oxide donor. Sonoki K; Iwase M; Iino K; Ichikawa K; Ohdo S; Higuchi S; Yoshinari M; Iida M Metabolism; 2003 Mar; 52(3):308-14. PubMed ID: 12647268 [TBL] [Abstract][Full Text] [Related]
2. Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor. Sonoki K; Yoshinari M; Iwase M; Iino K; Ichikawa K; Ohdo S; Higuchi S; Iida M Metabolism; 2002 Sep; 51(9):1135-42. PubMed ID: 12200757 [TBL] [Abstract][Full Text] [Related]
3. Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells. Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Takata Y; Iida M Br J Pharmacol; 2008 Apr; 153(7):1399-408. PubMed ID: 18264128 [TBL] [Abstract][Full Text] [Related]
4. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus. Sonoki K; Iwase M; Sasaki N; Ohdo S; Higuchi S; Matsuyama N; Iida M Diabetes Res Clin Pract; 2009 Nov; 86(2):117-23. PubMed ID: 19748147 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine contents in plasma LDL in patients with type 2 diabetes mellitus: relation with lipoprotein-associated phospholipase A2 and effects of simvastatin treatment. Iwase M; Sonoki K; Sasaki N; Ohdo S; Higuchi S; Hattori H; Iida M Atherosclerosis; 2008 Feb; 196(2):931-6. PubMed ID: 17350631 [TBL] [Abstract][Full Text] [Related]
6. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells. Takahara N; Kashiwagi A; Nishio Y; Harada N; Kojima H; Maegawa H; Hidaka H; Kikkawa R Diabetologia; 1997 Jun; 40(6):662-70. PubMed ID: 9222645 [TBL] [Abstract][Full Text] [Related]
7. IDL can stimulate atherogenic gene expression in cultured human vascular endothelial cells. Maeno Y; Kashiwagi A; Nishio Y; Takahara N; Kikkawa R Diabetes Res Clin Pract; 2000 May; 48(2):127-38. PubMed ID: 10802150 [TBL] [Abstract][Full Text] [Related]
8. Dilazep and fenofibric acid inhibit MCP-1 mRNA expression in glycoxidized LDL-stimulated human endothelial cells. Sonoki K; Iwase M; Iino K; Ichikawa K; Yoshinari M; Ohdo S; Higuchi S; Iida M Eur J Pharmacol; 2003 Aug; 475(1-3):139-47. PubMed ID: 12954370 [TBL] [Abstract][Full Text] [Related]
9. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1. Zoja C; Angioletti S; Donadelli R; Zanchi C; Tomasoni S; Binda E; Imberti B; te Loo M; Monnens L; Remuzzi G; Morigi M Kidney Int; 2002 Sep; 62(3):846-56. PubMed ID: 12164866 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. Kume N; Gimbrone MA J Clin Invest; 1994 Feb; 93(2):907-11. PubMed ID: 7509351 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. Wong JT; Tran K; Pierce GN; Chan AC; O K; Choy PC J Biol Chem; 1998 Mar; 273(12):6830-6. PubMed ID: 9506985 [TBL] [Abstract][Full Text] [Related]
12. Statin inhibits the expression of secretory phospholipase A2 and subsequent monocyte chemoattractant protein-1 in human endothelial cells. Sonoki K; Iwase M; Ohdo S; Ieiri I; Takata Y; Kitazono T J Cardiovasc Pharmacol; 2014 Dec; 64(6):489-96. PubMed ID: 25490414 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. Kume N; Cybulsky MI; Gimbrone MA J Clin Invest; 1992 Sep; 90(3):1138-44. PubMed ID: 1381720 [TBL] [Abstract][Full Text] [Related]
14. Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity. Sonoki K; Iwase M; Ohdo S; Ieiri I; Matsuyama N; Takata Y; Kitazono T J Cardiovasc Pharmacol; 2012 Oct; 60(4):367-74. PubMed ID: 22743636 [TBL] [Abstract][Full Text] [Related]
16. Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low-density lipoprotein. Ji Y; Diao J; Han Y; Huang Y; Bai H; Chen Q; Fan L; Ferro A Atherosclerosis; 2006 Sep; 188(1):84-94. PubMed ID: 16300769 [TBL] [Abstract][Full Text] [Related]
17. [Effect of Huoxue injection on oxidized low-density lipoprotein induced activation of human umbilical vein endothelial cells]. Zhu LQ; Wang SR; Zhao MJ; Cui W; Niu FL Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1617-21. PubMed ID: 18837329 [TBL] [Abstract][Full Text] [Related]
18. Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL. Benítez S; Camacho M; Arcelus R; Vila L; Bancells C; Ordóñez-Llanos J; Sánchez-Quesada JL Atherosclerosis; 2004 Dec; 177(2):299-305. PubMed ID: 15530903 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. Wang G; Siow YL; O K Biochem J; 2000 Dec; 352 Pt 3(Pt 3):817-26. PubMed ID: 11104691 [TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect. Mahfouz MM; Kummerow FA Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]